Amifampridine tablets are indicated for the treatment of Lambert-Eaton myasthenic syndrome in adults and pediatric patients 6 ...
and 20 mg tablets from Lupin and Taro are under tentative approval by the FDA. Over a dozen other generic manufacturers are ...
Two companies have received approved for a generic of the 2.5 mg tablet of anticoagulant rivaroxaban, which is used to reduce ...
Lupin Limited today announced that it has received tentative approval from the United States Food and Drug Administration for ...
to market a generic equivalent of Descovy® Tablets, 200 mg/25 mg of Gilead Sciences, Inc," Lupin said in an exchange filing. The approval allows Lupin to market a generic version of Descovy ...
has issued a tentative approval for Lupin Ltd’s Abbreviated New Drug Application (ANDA) for Amifampridine Tablets, 10 mg. The approval allows Lupin to enter the market for Lambert-Eaton ...